Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2002
06/20/2002WO2001083786A3 Stable zymomonas mobilis xylose and arabinose fermenting strains
06/20/2002WO2001083559A3 Production and use of protein variants having modified immunogenecity
06/20/2002WO2001083549A3 Novel polypeptides constituting pheromone receptors in rats, cloning and use thereof
06/20/2002WO2001083524A3 Rna metabolism proteins
06/20/2002WO2001081416A3 Human ion channel and uses thereof
06/20/2002WO2001079500A3 Streptococcus thermopilus operons involved in exopolysaccharide (eps) synthesis
06/20/2002WO2001079487A3 Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene
06/20/2002WO2001077379A3 A method of cell detection
06/20/2002WO2001077374A3 Method for identifying and isolating genome fragments with linkage disequilibrium
06/20/2002WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
06/20/2002WO2001075098A3 33166, a human hydrolase-like molecule and uses thereof
06/20/2002WO2001075076A3 33167, a novel human hydrolase and uses therefor
06/20/2002WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same
06/20/2002WO2001074897A3 Protein amf-1 to amf-10 and nucleic acids encoding the same
06/20/2002WO2001073086A3 Method for genetically modifying a plant
06/20/2002WO2001073059A3 38692 and 21117: dual specificity phosphatase molecules and uses therefor
06/20/2002WO2001073050A3 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
06/20/2002WO2001072961A3 Novel compounds
06/20/2002WO2001069230A3 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
06/20/2002WO2001068863A3 Plant and yeast polynucleotide sequences coding for proteins interacting with geminivirus proteins
06/20/2002WO2001068851A3 Polypeptides and nucleic acids encoding same
06/20/2002WO2001060857A3 Compositions useful for regulating parkin gene activity
06/20/2002WO2001059131A3 Use of palatinase and trehalulase sequences as nutritive markers in transformed cells
06/20/2002WO2001054771A3 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
06/20/2002WO2001053487A3 Human sperm specific lysozyme-like proteins
06/20/2002WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer
06/20/2002WO2001044445A8 Human lyases and associated proteins
06/20/2002WO2001042473B1 Device and method for accelerated hydration of dry chemical sensors
06/20/2002WO2001040461A3 Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and c
06/20/2002WO2001032693A3 Trp-protein-related mtr1 protein and dna sequence coding therefor
06/20/2002WO2001027154A3 Membrane translocating peptide drug delivery system
06/20/2002WO2001012659A3 Human dna sequences
06/20/2002WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof
06/20/2002WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof
06/20/2002WO2000065052A9 Bridge-1, a transcription factor
06/20/2002WO2000064935A9 A novel serotonin-gated anion channel
06/20/2002WO2000063413A9 Agrobacterium tumefaciens rpoa gene
06/20/2002WO2000061752A9 Modified complement system regulators
06/20/2002WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
06/20/2002WO2000061596A8 50 human secreted proteins
06/20/2002WO2000060126A3 Quantitative assay for expression of genes in microarray
06/20/2002WO2000052210A9 Methods for targeting rna molecules
06/20/2002WO2000052185A9 Application of dna vectors for the treatment of viral infection
06/20/2002WO2000052176A8 β-HEXOSAMINIDASE, DNA SEQUENCE FROM CILIATES FOR CODING THE SAME AND USE THEREOF
06/20/2002WO2000052159A9 Methods and reagents for inhibiting proliferation of smooth muscle cells
06/20/2002WO2000052158A9 Methods and reagents for inhibiting angiogenesis
06/20/2002WO2000050596A9 14273 receptor, a novel g-protein coupled receptor
06/20/2002US20020078478 Nucleotide sequences coding insecticidal proteins; for use in biological pest control
06/20/2002US20020078477 Generating transgenic plant; obtain cells, transform, monitor preferential gene exprtession from cells
06/20/2002US20020078476 Methods and compositions relating to the generation of partially transgenic organisms
06/20/2002US20020078474 Genetic engineering of syringyl-enriched lignin in plants
06/20/2002US20020078473 Pesticides
06/20/2002US20020078472 Methods and means for expression of mammalian polypeptides in monocotyledonous plants
06/20/2002US20020078471 Inhibition of gene expression using polynucleotide analogues
06/20/2002US20020078470 Method of producing non-human mammals
06/20/2002US20020077471 Methods for improving the sequence fidelity of synthetic double-stranded oligonucleotides
06/20/2002US20020077468 Corticotropin-releasing factor2 receptors
06/20/2002US20020077466 Protein for use in the diagnosis, prevention and treatment of nervous system and cell proliferation, kidney and urogenital disorders
06/20/2002US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis
06/20/2002US20020077464 Novel human neurexin-like proteins and polynucleotides encoding the same
06/20/2002US20020077462 Nucleotide sequences coding transport protein for use in treatment of nervous system, cardiovascular, muscular, immunological, cell proliferation and differentiation disorders
06/20/2002US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
06/20/2002US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects
06/20/2002US20020077457 Nucleotide sequences coding binding protein for use as diagnostic tools in genetic engineering
06/20/2002US20020077365 Method for increasing the effectiveness of antiinfective
06/20/2002US20020077313 Methods and compositions for the diagnosis and treatment of cancer
06/20/2002US20020077312 Inhibiting 3700 protein activity in the cell, whereby the ability of the cell to phosphorylate amino acid residue of a substrate protein is modulated
06/20/2002US20020077311 Genetically-engineered myoblasts and cardiac myocytes as drug delivery systems
06/20/2002US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders
06/20/2002US20020077308 Methods of treating colitis using STAT-4 anti-sense oligonucleotides
06/20/2002US20020077307 Methods for regulating gene expression
06/20/2002US20020077305 Genetic immunization with cationic lipids
06/20/2002US20020077298 Anti-fungal peptides
06/20/2002US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease
06/20/2002US20020077273 Methods of using agents that modulate bone formation and inhibit adipogenesis
06/20/2002US20020077272 Contacting bacteria with an agent that alters the bacteria's native level of DNA methyltransferase (Dam) activity thereby altering the bacteria's native level of methylation of adenine in a GATC tetranucleotide of the bacteria
06/20/2002US20020076823 Near infrared chemiluminescent acridinium compounds and uses thereof
06/20/2002US20020076811 Mammalian artificial chromosomes
06/20/2002US20020076808 Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products
06/20/2002US20020076801 AAV DNA comprising helper virus sequences
06/20/2002US20020076800 Protein
06/20/2002US20020076798 Liver-specific gene expression cassettes, and methods of use
06/20/2002US20020076797 Purified and isolated piwi family genes and gene products and methods using same
06/20/2002US20020076796 2786, a novel human aminopeptidase
06/20/2002US20020076795 Novel TRF1 binding protein, methods of use thereof
06/20/2002US20020076794 Mammalian pro-apoptotic Bok genes and their uses
06/20/2002US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4
06/20/2002US20020076792 Glucanase for use in animal feeds, paper making and textile processing
06/20/2002US20020076791 Cultured rodent cells; for use in generation of heterologous proteins
06/20/2002US20020076788 Nucleotide sequences coding enzymatic polypeptide for use as tools in genetic engineering
06/20/2002US20020076787 Increasing the replicative capacity of normally quiescent cells, such as normal somatic cells, by transient immortalization or transient telomerization, to produce cells suitable for gene therapy
06/20/2002US20020076784 Nucleotide sequences coding preferential polypeptide for use in the treatment of brain disorders, infections and viral diseases
06/20/2002US20020076783 Plants and plants cells expressing histidine tagged intimin
06/20/2002US20020076780 Novel human ion channel proteins and polynucleotides encoding the same
06/20/2002US20020076779 Polypeptide for use in the treatment of cancer
06/20/2002US20020076777 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
06/20/2002US20020076775 WRKY transcription factors and methods of use
06/20/2002US20020076770 Generating pantothenic acid; obtain microorganism, culture, propagate, recover pantothenic acid
06/20/2002US20020076766 Novel glucosaminidase
06/20/2002US20020076764 27877, a novel phospholipase and uses therefor